help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 5, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-0066
A more recent version of this article appeared on August 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/8/3060    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hale, G. E.
Right arrow Articles by Fraser, I. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hale, G. E.
Right arrow Articles by Fraser, I. S.
Related Collections
Right arrow Neuroendocrinology and Pituitary
Right arrow Diabetes and Insulin
Right arrow Metabolism

Submitted on January 11, 2007
Accepted on May 24, 2007

Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system

Georgina E. Hale*, Xue Zhao, Claude L. Hughes, Henry G. Burger, David M. Robertson, and Ian S. Fraser

Department of Obstetrics and Gynaecology, QE II Building (DO2) University of Sydney, NSW, 2006, Australia, 2006; RTI International Research Triangle Park, NC 27709, Prince Henry's Institute, Monash Medical Centre, Clayton, VIC, Australia, 3168

* To whom correspondence should be addressed. E-mail: ghale{at}med.usyd.edu.au.

Context: Female reproductive aging based on changes in menstrual cycle length and frequency, progresses through a number of stages as defined by the STRAW (Stages of Reproductive Aging Workshop) staging criteria.

Objective: This paper provides a comprehensive description of the endocrine features associated with the STRAW stages.

Design: Healthy women aged 21-35 and 45-55 submitted three blood samples a week for over a single menstrual cycle. They were classified as mid-reproductive age (MRA; N=21), late reproductive age (LRA; N=16), early menopause transition (EMT; N=16) and late menopause transition (LMT; N=23).

Results: There were 9, 1, 0 and 2 anovulatory cycles identified in the LMT, EMT, LRA and MRA groups respectively. Ovulatory cycle FSH, LH and estradiol (E2) levels increased with progression of STRAW stage (P = 0.001; P < 0.01; P < 0.05 respectively), and mean luteal phase serum progesterone decreased (P < 0.01). Early cycle (ovulatory and anovulatory) inhibin B (INHB) decreased steadily across the STRAW stages (P < 0.01) and was largely undetectable during elongated ovulatory and anovulatory cycles in the menopause transition. Anti-Mullerian Hormone (AMH) decreased markedly (10-15 fold) and progressively across the STRAW stages (P < 0.01; P < 0.001 respectively).

Conclusions: Progression through the STRAW Stages is associated with elevations in serum FSH, LH, E2 and decreases in luteal phase P. The marked fall in INHB and particularly AMH indicate that they may be useful in predicting STRAW Stage but future analyses of early cycle measurements on larger cohorts are needed to draw predictive conclusions.


Key words: Menopause transition • perimenopause • estradiol • progesterone • follicular stimulating hormone • luteinizing hormone • inhibin A • inhibin B • hormonal dynamics • menstrual cycle




This article has been cited by other articles:


Home page
Hum ReprodHome page
J. Rohr, E.G. Allen, K. Charen, J. Giles, W. He, C. Dominguez, and S.L. Sherman
Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study
Hum. Reprod., May 1, 2008; 23(5): 1220 - 1225.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society